Clinical Trials on Hydatidiform Mole, Invasive

Total 12357 results

Hospices Civils de Lyon

Recruiting

The French National Reference Centre of GTD (French GTDC)

Hydatidiform Mole | Gestational Trophoblastic Disease | Neoplasm, Trophoblastic | Hydatidiform Mole, Invasive

France
Baylor College of Medicine

Active, not recruiting

Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles

Hydatidiform Moles

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors

Non-Metastatic Gestational Trophoblastic Tumor | Complete Hydatidiform Mole | Partial Hydatidiform Mole

United States, Canada
King's College Hospital NHS Trust
University College, London

Recruiting

The Accuracy of Ultrasound Diagnosis of Hydatidiform Moles

Abortion, Spontaneous | Missed Abortion | Miscarriage in First Trimester | Incomplete Miscarriage | Hydatidiform Mole (Diagnosis)

United Kingdom
Nilratan Sircar Medical College

Unknown

A Comparison of Single Versus Double Evacuation for Treatment of Hydatidiform Mole

Hydatidiform Mole

India
Women's Hospital School Of Medicine Zhejiang University

Not yet recruiting

A Cohort Study of Hydatidiform Mole

Hydatidiform Mole
University of the Philippines

Completed

RCT on the Efficacy of Methotrexate for the Prevention of GTD

Hydatidiform Mole

Philippines
Women's Hospital School Of Medicine Zhejiang University

Recruiting

Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule

Hydatidiform Mole | Gestational Trophoblastic Neoplasia

China
Brigham and Women's Hospital
Universidade Federal do Rio de Janeiro; Maternidade Escola da Universidade... and other collaborators

Recruiting

Second Uterine Evacuation for Low-risk Gestational Trophoblastic Neoplasia (ReCure)

Gestational Trophoblastic Neoplasia | Molar Pregnancy | Gestational Trophoblastic Tumor, Non-Metastatic

Brazil
Centre Hospitalier Universitaire Vaudois

Unknown

Breakthrough Invasive Mold Infections Under Posaconazole Prophylaxis (BIMI) (BIMI)

Hematologic Diseases | Hematologic Malignancy | Invasive Mold Infections | Breakthrough Invasive Mold Infections

Switzerland, Austria, Germany
Melbourne Health
Merck Sharp & Dohme LLC

Recruiting

Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants (POPULAR)

Fungal Infection | Pharmacokinetics | Invasive Aspergillosis | Prophylaxis | Invasive Candidiases | Posaconazole | Invasive Mycosis

Australia
Medical University of Graz
Barmherzige Brueder Marschallgasse / Graz

Completed

Influence of Open and Laparoscopic Abdominal Surgery Involving the Intestinal Tract on Serum 1,3-ß-D-Glucan (BDG) Values

Invasive Candidiases

Austria
Duke University
National Institute of Allergy and Infectious Diseases (NIAID); Children's Hospital...

Completed

PEACE: Pediatric Antifungal Comparative Effectiveness (PEACE)

Pediatric Invasive Candidiasis

United States, Colombia, Canada, India, Saudi Arabia, Greece, Italy, Spain
Cidara Therapeutics Inc.

Recruiting

Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (ReSPECT)

Mycoses | Candidemia | Fungemia | Fungal Infection | Invasive Candidiasis | Invasive Fungal Disease | Pneumocystis | Mold Infection | Prophylaxis of Invasive Fungal Infections | Aspergillus

United States, Germany, France, Belgium, Canada, Italy, Spain, United Kingdom, Turkey, Switzerland
University of Cologne

Recruiting

ECMM Candida Registry - CandiReg (CandiReg)

Invasive Candidiases

Germany
CSPC Ouyi Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus

Invasive Aspergillosis | Invasive Candidiasis

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Unknown

Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive Aspergillosis

Invasive Aspergillosis | Invasive Candidiasis
Centre Hospitalier Universitaire Dijon

Completed

Evaluate the Performance of Genetic Amplification by Polymerase Chain Reaction (PCR) and the "Mannan Antigenemia and Antimannan Antibodies Couple as a Means of Diagnosis and a Marker of Follow-up in Invasive Candidiasis. (EMPIRICAND)

Invasive Candidiasis; Treatment With Echinocandin

France
Aura Biosciences

Recruiting

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

Muscle-Invasive Bladder Carcinoma | Non-muscle-invasive Bladder Cancer

United States
University of Bologna

Unknown

A B-D-Glucan Driven Antifungal Stewardship Approach for Invasive Candidiasis

Invasive Candidiases | Abdominal Infection

Italy
Eli Lilly and Company
Gynecologic Oncology Group

Completed

A Trial for Patients With Gestational Trophoblastic Disease

Uterine Neoplasms | Trophoblastic Neoplasms | Hydatidiform Mole | Choriocarcinoma

United States
Medical University of Graz
Medical University Innsbruck

Completed

NOBICS - NOvel BIomarker In Invasive CandidiasiS/Candida Sepsis (NOBICS)

Invasive Candidiasis

Austria
Fadoi Foundation, Italy

Terminated

Comparison of Two Diagnostic Tests in Patients With Suspected Invasive Candidiasis in Internal Medicine Wards and Who Are Currently Timely Treated With Micafungin (EPICA1)

Invasive Candidiasis

Italy
Kevin Watt

Completed

Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation

Invasive Candidiasis

United States
Duke University
Pfizer

Completed

β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients

Invasive Candidiasis

United States
University Hospital, Lille

Recruiting

Early Discontinuation of Empirical Antifungal Therapy and Biomarkers (SEAT)

Invasive Candidiasis

France
University Hospital, Limoges

Completed

Pharmacokinetics of Micafungin in Patients of Intensive Care Units (MI-K)

Invasive Candidiasis

France
University Medical Center Groningen

Completed

Variability of Fluconazole Concentration in Critically Ill Patients

Invasive Candidiasis

Netherlands
Merck Sharp & Dohme LLC

Completed

A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED)

Invasive Candidiasis
Merck Sharp & Dohme LLC
Mycoses Study Group

Terminated

Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067)

Invasive Candidiasis
University Hospital, Grenoble

Completed

Empirical Antifungal Treatment in ICUS (EMPIRICUS)

Invasive Candidiasis

France
Mycoses Study Group
Merck Sharp & Dohme LLC

Completed

Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU) (MSG-01)

Invasive Candidiasis

United States
Yung Shin Pharm. Ind. Co., Ltd.

Completed

Evaluate Bioequivalence of Micafungin (50mg/Vial)

Invasive Candidiasis

Taiwan
Duke University
Children's Hospital of Philadelphia

Completed

BIOPIC: Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric Candidemia (BIOPIC)

Invasive Candidiasis

United States, Saudi Arabia, Greece, Spain
Merck Sharp & Dohme LLC

Terminated

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)

Candidiasis, Invasive
Hasan Al-Dorzi
King Fahad Medical City

Completed

Invasive Candidiasis in Saudi ICUs (ICIP-SA)

Invasive Candidiasis

Saudi Arabia
Pfizer
Vicuron Pharmaceuticals

Completed

The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.

Candidiasis

United States
University Medical Center Groningen

Completed

Optimal Dosage of Caspofungin in Critically Ill Patients

Critically Ill | Suspected Invasive Candidiasis

Netherlands
Nucleix Ltd.

Completed

Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer

Non Muscle Invasive Bladder Cancer | Non-Muscle Invasive Bladder Urothelial Carcinoma

United States
Hospital Universitario La Fe

Completed

Predictive Factors of Mortality in Invasive Fungal Disease in Post-surgical Critical Care Unit (FPR-IIS)

Fungal Invasive Disease

Spain
Astellas Pharma Inc

Completed

A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects (INTENSE)

Mycoses

Belgium, Germany, Spain, France, Italy, Turkey, Austria, Switzerland, Hungary, United Kingdom, Israel, Denmark, Greece, Finland, Romania
Pfizer

Completed

An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris (APEX)

Candidemia | Candida Infection | Invasive Candidiases

South Africa
AstraZeneca
Hospital Israelita Albert Einstein

Recruiting

Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

Urothelial Carcinoma | Muscle-invasive Bladder Cancer | Non Muscle Invasive Bladder Cancer

Brazil
Robert Krause, MD

Completed

Candida Spp. in the Lower Respiratory Tract: Harmless Residents or Pathogen?

Invasive Candidiasis | Pulmonary Candidiasis

Austria
Mayo Clinic

Recruiting

The Role Of Interferon-gamma In Immune Responses To Invasive Candidiasis

Candidiasis | Fungal Infection

United States
Merck Sharp & Dohme LLC

Completed

A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066)

Fungal Infection
University of Roma La Sapienza

Not yet recruiting

Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs) (CUT-less)

Non-muscle-invasive Bladder Cancer | Non-Muscle Invasive Bladder Urothelial Carcinoma | High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
Services Institute of Medical Sciences, Pakistan

Completed

Efficacy of Prophylactic Fluconazole Therapy in Preterm and Very Low Birth Weight Neonates in Preventing Invasive Fungal Infection.

Invasive Candidiases

Pakistan
Fundacion Oncosur
Apices Soluciones S.L.

Active, not recruiting

Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE) (BladderGATE)

Invasive Bladder Cancer

Spain
Fujian Shengdi Pharmaceutical Co., Ltd.

Not yet recruiting

A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis

Patients With Candidemia and/or Invasive Candidiasis

Clinical Trials on Hydatidiform Mole, Invasive

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations